SIGNAL TRANSDUCTION BY CALCINEURIN IN T LYMPHOCYTES

T 淋巴细胞中钙调磷酸酶的信号转导

基本信息

  • 批准号:
    2701836
  • 负责人:
  • 金额:
    $ 13.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-05-01 至 2002-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: (Adapted from the investigator's abstract) The major goal of this proposal is to gain a molecular understanding of the mechanism of signal transduction by calcineurin during activation of T lymphocytes. The investigator has identified calcineurin as an important enzyme in the T cell receptor (TCR)-mediated signal transduction pathway leading to interleukin-2 (IL-2) production and as a common target for the immunosuppressive drugs cyclosporin A and FK506. Calcineurin is known to modulate the activities of at least three distinct classes of transcription factor including NF-AT, NF-kB and AP-1. However, many of the signaling molecules involved in the activation of NF-kB and AP-1 by calcineurin are not known. Calcineurin exists in multiple isoforms; it has been assumed that the a isoform of calcineurin mediates TCR signaling. Recently, calcineurin a was knocked out in mice, but no defect in the TCR-mediated IL-2 production was observed. In his preliminary studies, he has found that another isoform, calcineurin b, is more abundant than calcineurin a in T cells, suggesting that calcineurin b may play a dominant role in TCR signaling. Using FK506-resistant calcineurin mutants, he proposes to assess whether calcineurin b is sufficient to mediate TCR signaling. He will apply the yeast two-hybrid system to identify the substrates and associated proteins for calcineurin b to uncover signaling molecules involved in the activation of NF-kB and AP-1 by calcineurin. Alternatively, he will also employ catalytically inactive calcineurin mutants to identify calcineurin substrates from Jurkat cell extracts in vitro. Using partial cDNA sequences obtained from the yeast two-hybrid screen or oligopeptide sequences obtained from in vitro binding, the full length cDNA encoding putative calcineurin substrates and associated proteins will be cloned and further characterized in the context of TCR signaling. The identification of new signaling molecules through these studies will not only shed light on the molecular mechanism of TR signal transduction, but will also offer new targets for designing more specific and less toxic immunosuppressants.
描述:(改编自研究者的摘要)的主要目标

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jun O. Liu其他文献

Binding of thalidomide to alpha1-acid glycoprotein may be involved in its inhibition of tumor necrosis factor alpha production.
沙利度胺与 α1-酸性糖蛋白的结合可能参与其抑制肿瘤坏死因子 α 的产生。
suppresses the oncogenic activity of YAP YAP complex - Genetic and pharmacological disruption of the TEAD
抑制 YAP YAP 复合物的致癌活性 - TEAD 的遗传和药理学破坏
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Y. Liu;Bo Huang;J. Shim;Qian Chen;Se;Robert A. Anders;Jun O. Liu;Duojia Pan
  • 通讯作者:
    Duojia Pan
Phase of the Cell Cycle 1 IL-2-Dependent T Cell Proliferation at the G Immunosuppressant, Inhibits Sanglifehrin A, a Novel Cyclophilin-Binding
细胞周期 1 阶段 IL-2 依赖性 T 细胞在 G 处增殖 免疫抑制剂抑制 Sanglifehrin A(一种新型亲环蛋白结合)
  • DOI:
  • 发表时间:
    2001
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Ling;Jun O. Liu
  • 通讯作者:
    Jun O. Liu
Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells.
TNP-470 和卵黄素在内皮细胞中选择性抑制氨基末端甲硫氨酸加工。
  • DOI:
  • 发表时间:
    1999
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Benjamin E. Turk;Eric C. Griffith;Susan M. Wolf;Klaus Biemann;Yie;Jun O. Liu
  • 通讯作者:
    Jun O. Liu
Girolline is a sequence context-selective modulator of eIF5A activity
吉罗啉是一种 eIF5A 活性的序列上下文选择性调节剂
  • DOI:
    10.1038/s41467-024-54838-2
  • 发表时间:
    2025-01-10
  • 期刊:
  • 影响因子:
    15.700
  • 作者:
    Tilman Schneider-Poetsch;Yongjun Dang;Wakana Iwasaki;Mayumi Arata;Yuichi Shichino;Ali Al Mourabit;Celine Moriou;Daniel Romo;Jun O. Liu;Takuhiro Ito;Shintaro Iwasaki;Minoru Yoshida
  • 通讯作者:
    Minoru Yoshida

Jun O. Liu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jun O. Liu', 18)}}的其他基金

Characterization of A Novel Proteasome Inhibitor
新型蛋白酶体抑制剂的表征
  • 批准号:
    10597711
  • 财政年份:
    2022
  • 资助金额:
    $ 13.62万
  • 项目类别:
Targeting Glucose Transporters Using Rapafucins
使用雷帕夫星靶向葡萄糖转运蛋白
  • 批准号:
    10335197
  • 财政年份:
    2020
  • 资助金额:
    $ 13.62万
  • 项目类别:
Targeting Glucose Transporters Using Rapafucins
使用雷帕夫星靶向葡萄糖转运蛋白
  • 批准号:
    10557907
  • 财政年份:
    2020
  • 资助金额:
    $ 13.62万
  • 项目类别:
Studies of the Antifungal Drug Itraconazole As A Novel Inhibitor of Angiogenesis
抗真菌药物伊曲康唑作为新型血管生成抑制剂的研究
  • 批准号:
    8817767
  • 财政年份:
    2015
  • 资助金额:
    $ 13.62万
  • 项目类别:
Generation and Proteome-Wide Screening of Hybrid Combinatorial Libraries
混合组合文库的生成和全蛋白质组筛选
  • 批准号:
    8520275
  • 财政年份:
    2010
  • 资助金额:
    $ 13.62万
  • 项目类别:
Generation and Proteome-Wide Screening of Hybrid Combinatorial Libraries
混合组合文库的生成和全蛋白质组筛选
  • 批准号:
    8323364
  • 财政年份:
    2010
  • 资助金额:
    $ 13.62万
  • 项目类别:
Generation and Proteome-Wide Screening of Hybrid Combinatorial Libraries
混合组合文库的生成和全蛋白质组筛选
  • 批准号:
    8151102
  • 财政年份:
    2010
  • 资助金额:
    $ 13.62万
  • 项目类别:
Generation and Proteome-Wide Screening of Hybrid Combinatorial Libraries
混合组合文库的生成和全蛋白质组筛选
  • 批准号:
    7979320
  • 财政年份:
    2010
  • 资助金额:
    $ 13.62万
  • 项目类别:
Generation and Proteome-Wide Screening of Hybrid Combinatorial Libraries
混合组合文库的生成和全蛋白质组筛选
  • 批准号:
    8705479
  • 财政年份:
    2010
  • 资助金额:
    $ 13.62万
  • 项目类别:
Discovery and Investigation of Novel Angiogenesis Inhibitors Among Existing Drugs
现有药物中新型血管生成抑制剂的发现和研究
  • 批准号:
    7351352
  • 财政年份:
    2008
  • 资助金额:
    $ 13.62万
  • 项目类别:

相似海外基金

Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2022
  • 资助金额:
    $ 13.62万
  • 项目类别:
    Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10581488
  • 财政年份:
    2022
  • 资助金额:
    $ 13.62万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574979-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 13.62万
  • 项目类别:
    University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10332251
  • 财政年份:
    2022
  • 资助金额:
    $ 13.62万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574984-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 13.62万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574985-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 13.62万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574978-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 13.62万
  • 项目类别:
    University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
  • 批准号:
    444149
  • 财政年份:
    2021
  • 资助金额:
    $ 13.62万
  • 项目类别:
    Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
  • 批准号:
    RGPIN-2015-05491
  • 财政年份:
    2021
  • 资助金额:
    $ 13.62万
  • 项目类别:
    Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2021
  • 资助金额:
    $ 13.62万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了